RF vs ZNTL · rev $1.75B vs $257.7M cap
RF (RF) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
RF (RF) common stock.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported RF revenue for 2026-06-30 was $1.75B. Net income was $570.0M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. RF currently screens at market cap $0.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
RF currently screens at market cap $0. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the RF and ZNTL stock pages for the full models.
Not investment advice.